• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Extraction and analytic procedures for cytosine arabinoside and 1-beta-D-arabinofuranosyluracil and their 5'-mono-, di-, and tri-phosphates.

作者信息

Kreis W, Gordon C, Gizoni C, Woodcock T

出版信息

Cancer Treat Rep. 1977 Jul;61(4):643-6.

PMID:195728
Abstract

A qualitative and quantitative comparison of perchloric acid (PCA) and trichloroacetic acid (TCA) extraction procedures of biologic material containing cytosine arabinoside (Ara-C) and 1-beta-D-arabinofuranosyluracil (Ara-U) and their biologic 5'-phosphate derivatives revealed definite superiority of the PCA procedure over the TCA procedure. High-pressure liquid chromatography provides rapid and accurate quantitative and qualitative separation of both Ara-C and Ara-U and their 5'-mono-, di-, and tri-phosphates (mu Bondapak NH2 column), or their 5'-mono-, di-, and tri-phosphates without nucleosides (ABX Permaphase columns).

摘要

相似文献

1
Extraction and analytic procedures for cytosine arabinoside and 1-beta-D-arabinofuranosyluracil and their 5'-mono-, di-, and tri-phosphates.
Cancer Treat Rep. 1977 Jul;61(4):643-6.
2
Separation of 5'-mono-, di- and triphosphates of 1-beta-D-arabinofuranosylcytosine and of 1-beta-D-arabinofuranosyluracil by thin-layer and high pressure liquid chromatography.
J Chromatogr Sci. 1976 Jul;14(7):331-3. doi: 10.1093/chromsci/14.7.331.
3
A radioimmunoassay method for 1-beta-D-arabinofuranosyluracil using antibodies directed against 1-beta-D-arabinofuranosylcytosine.
Cancer Res. 1977 Feb;37(2):625-8.
4
Sensitive radioimmunoassay for cytarabine and uracil arabinoside in plasma.血浆中阿糖胞苷和阿糖尿苷的灵敏放射免疫测定法。
Cancer Treat Rep. 1984 Nov;68(11):1357-66.
5
A radioimmunoassay for 1-beta-D-arabinofuranosyluracil with reference to cross-reactivity of 1-beta-D-arabinofuranosylcytosine with an antibody.
Cancer Res. 1977 Sep;37(9):3132-5.
6
High-performance liquid chromatographic assay for cytosine arabinoside, uracil arabinoside and some related nucleosides.用于测定阿糖胞苷、阿糖尿苷及一些相关核苷的高效液相色谱分析法
J Chromatogr. 1983 May 13;274:87-93. doi: 10.1016/s0378-4347(00)84411-4.
7
Determination of 3H-labelled cytosine arabinoside and eight metabolites in cell extracts by high-performance liquid chromatography and scintillation spectrometry.采用高效液相色谱法和闪烁光谱法测定细胞提取物中3H标记的阿糖胞苷及其八种代谢物。
J Chromatogr. 1989 Jul 21;491(2):331-40. doi: 10.1016/s0378-4347(00)82851-0.
8
Simultaneous determination of cytosine arabinoside and its metabolite, uracil arabinoside, in human plasma using hydrophilic interaction liquid chromatography with UV detection.采用亲水作用液相色谱-紫外检测法同时测定人血浆中的阿糖胞苷及其代谢物阿糖尿苷。
Biomed Chromatogr. 2013 Jul;27(7):818-20. doi: 10.1002/bmc.2876. Epub 2013 Feb 19.
9
Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.阿糖胞苷(ara-C)与阿糖尿苷(ara-U)或四氢尿苷(THU)联合化疗对荷瘤小鼠体内鼠白血病L1210/0的药理作用。
Cancer Invest. 1987;5(4):293-9.
10
Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice.1-β-D-阿拉伯呋喃糖基尿嘧啶对白血病小鼠体内1-β-D-阿拉伯呋喃糖基胞嘧啶代谢及药代动力学的调节作用
Cancer Res. 1989 Jun 15;49(12):3259-66.

引用本文的文献

1
The practical benefits of pharmacokinetics in the use of antineoplastic agents.药代动力学在抗肿瘤药物使用中的实际益处。
Cancer Chemother Pharmacol. 1980;4(3):139-45. doi: 10.1007/BF00254011.
2
The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemia.急性髓性白血病患者皮下注射阿糖胞苷的药代动力学
Br J Clin Pharmacol. 1981 Oct;12(4):507-10. doi: 10.1111/j.1365-2125.1981.tb01258.x.
3
A radioimmunoassay for cytosine arabinoside.阿糖胞苷的放射免疫测定法。
Br J Cancer. 1979 Oct;40(4):548-56. doi: 10.1038/bjc.1979.220.